Natco Pharma lines up 20 `Para IV’ products

Para IV products mean, “the first company which submits a completed ANDA (Abbreviated New Drug Application) getting marketing exclusivity for 180 days.” Natco Pharma has in the pipeline a 20 key `Para IV’ products of which some are expected to be launched in due course. According to the US Food and Drug Administration (USFDA) norms, a company can seek approval from FDA to market a generic drug before the expiration of a patent relating to the brand name upon which the generic is based. Para IV products Normally, the first company…

Read More